Clistin

Active Ingredient(s): Carbinoxamine
Pharm Company: * ORTHO MCNEIL PHARM
Category: Allergies, Cough & Cold

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Clistin Overview

Carbinoxamine (Clistin, Palgic, Rondec, Rhinopront) is a antihistamine and anticholinergic agent. It was first launched in the United States by the McNeil Corporation under the brand name Clistin. It is now available under the brand name Palgic as 4 mg tablets or 4 mg/5 mL liquid. It is approved by the U.S. Food and Drug Administration (FDA) (specifically at the 4 mg dose/strength) for hay fever (a.k.a. allergic rhinitis, SAR and PAR); vasomotor rhinitis; mild urticaria; angioedema, dermatogr...

Read more Clistin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Carbinoxamine

Recent Clistin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Carbinoxamine
  • Capsule, Modified Release: 2mg + 8mg
  • Elixir: 4mg/5ml
  • Liquid: 1.5mg/5ml, 1.75mg/5ml, 2mg/5ml, 4mg/5ml
  • Solution: 4mg/5ml
  • Suspension: 3.6mg/5ml
  • Suspension, Extended Release: 4mg/5ml
  • Suspension, Modified Rele: 2mg/5ml + 6mg/5ml
  • Tablet: 4mg
  • Tablet, Extended Release: 8mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Carbinoxamine or a similar ingredient: (39 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA